In the second experiment, we used DARPA 1999 dataset for training three anomaly detection models, which are the PCA-based TMAD, LDA-based GSAD and McPAD.
Since GSAD and PCA-Based TMAD used a payload length of 185 and 150 bytes, respectively, the data pre-processing complexity is 0(1).
To classify a payload q, TMAD, PCA-based TMAD, and LDA-Based GSAD computed the Mahalanobis distance between the payload.
Decreased serotonin levels are associated with GSAD and OCD.
The FDA based its approval of extended-release fluvoxamine on data from 3 clinical trials with positive outcomes: 2 for GSAD and 1 for OCD (Table 2).
Table 3 Extended-release fluvoxamine: Adverse events * Study Adverse events Both GSAD Abnormal ejaculation, anorexia, and OCD studies anorgasmia, asthenia, diarrhea, nausea, somnolence, sweating, tremor GSAD studies only Dyspepsia, dizziness, insomnia, yawning OCD study only Accidental injury, anxiety, decreased libido, myalgia, pharyngitis, emesis * Includes events with an incidence [greater than or equal to]5% and at least twice that of placebo GSAD: generalized social anxiety disorder; OCD: obsessive-compulsive disorder Source: References 3-6